PREMs In Vascular SurgERy Enhancement Study
PREMIERE
Patient-Reported Experience Measures in Vascular Surgery Enhancement Study
2 other identifiers
observational
330
1 country
1
Brief Summary
THE PROBLEM: Patient Reported Experience Measures (PREMs) ask patients about their healthcare service experience. It gives them a voice to share their views. PREMs allow healthcare providers (HCPs) to see where care is good, and where they could improve. Vascular surgery is a surgical speciality looking after people's blood vessels (arteries and veins). There is no PREM available for vascular patients. The research team want to create a PREM for this patient group. WHY IT IS IMPORTANT: A PREM allows HCPs to record and understand patients' experiences of their treatment. It gives patients a way to provide feedback on their healthcare experience. PREMs can help HCPs make changes to patients' care, identifying areas of good practice and areas for improvement. The Welsh Government is keen to support the use of PREMs. AIMS: To develop a PREM specific to vascular surgery patients. RESEARCH PLAN: The research team will summarise the literature about PREMs in surgery. The research team will then run focus groups and interviews with patients and staff to create a 'draft' PREM for vascular patients in Wales. The 'draft' PREM will be translated into Welsh. In the second phase, a larger number of vascular patients (100-300 depending on how long the 'draft' PREM is) from hospitals across Wales will complete the questionnaire. Statistical tests will look at the results to see if the questionnaire works well to capture patients' experiences. Based on these results, small changes will be made to make the 'draft' PREM better. This will make sure the 'final PREM' is ready for widespread use in Wales and beyond. PATIENT AND PUBLIC INVOLVEMENT: The patients' experience team at CAVUHB has reviewed our patients' materials. Our research team includes PPI co-applicants (DC and AH). DC a double amputee who has had many vascular operations. DC has experience raising awareness about vascular disease through public forums like the Limbless Association Charity and BBC Radio Wales. AH has issues with her leg due to smoking and had a keyhole operation to help with that. She had some problems after the procedure This is her first time as a PPI representative. DC and AH supported our research design and will be steering group members. Also, our research focuses on giving patients a voice and will include patients across Wales. A diverse group of patients will be involved across all stages of the PREM development.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 9, 2024
CompletedFirst Posted
Study publicly available on registry
April 12, 2024
CompletedStudy Start
First participant enrolled
June 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2026
ExpectedApril 15, 2024
April 1, 2024
1.2 years
April 9, 2024
April 12, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Degree of Validity of the PREM
Validity: The extent to which a measure assesses what it intends to measure.
Day 0, Day 30
Degree of Reliability of the PREM
Reliability: The consistency and stability of a measure over time and across different conditions.
Day 0, Day 30
Degree of Responsiveness of the PREM
Responsiveness: The ability of a measure to detect change over time in the concept being measured.
Day 0, Day 30
Degree of Feasibility of implementing the PREM in clinical practice
Feasibility: The practicality and suitability of implementing a measure in a specific setting or context.
Day 0, Day 30
Eligibility Criteria
Patients undergoing in-patient vascular care, which involves specialized vascular surgery for hospital-admitted individuals, including those recently discharged with conditions like peripheral artery disease. Recruitment will engage patients preoperatively and post-service (within 1-3 months) to minimize bias. The study will target UK's central vascular units for diverse patient demographics. Consistent eligibility criteria will apply to both study phases (development and validation).
You may qualify if:
- Patients who have recently (within the last three months) undergone a vascular procedure or intervention under the care of a vascular surgery team in the inpatient setting.
- Adults aged 18 years or older
- Not cognitively impaired (as determined by medical reports and/or self-reporting).
- Willing and able to provide written consent for participation.
- Able to speak, read and write English or Welsh
You may not qualify if:
- Patients who lack capacity or suffer from cognitive impairment.
- Patients who are unable to speak, read and write English or Welsh.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Southeast Wales Vascular Network-Cardiff and Vale University Health Board
Cardiff, Wales, United Kingdom
Related Publications (1)
Darwish M, Palmer R, Coulson J, Bosanquet DC, Withers K. Patient-Reported Experience Measures in Vascular Surgery Enhancement (PREMIERE) study: protocol for a mixed-methods study to develop and validate a vascular surgery-specific patient-reported experience measure. BMJ Open. 2025 Jul 5;15(7):e089240. doi: 10.1136/bmjopen-2024-089240.
PMID: 40617619DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
David C Bosanquet, FRCS
CARDIFF & VALE UNIVERSITY LHB
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 9, 2024
First Posted
April 12, 2024
Study Start
June 1, 2024
Primary Completion
August 1, 2025
Study Completion (Estimated)
June 1, 2026
Last Updated
April 15, 2024
Record last verified: 2024-04
Data Sharing
- IPD Sharing
- Will not share
The full dataset is not expected to be made available for secondary research. In accordance with standard measures to prevent statistical disclosure, quantitative data relating to five or fewer individuals will be aggregated or redacted prior to publication. Similarly, full focus group transcripts will not be made available to external individuals or organisations due to the possibility of statistical disclosure from these qualitative data.